mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.1 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.1 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |